Hongyang Wu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A retrospective study on the efficacy and safety of Envafolimab, a PD-L1 inhibitor, in the treatment of advanced malignant solid tumors.
Journal: Frontiers in pharmacology
Published: December 14, 2023
Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance.
Journal: Frontiers in oncology
Published: September 25, 2022
Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort.
Journal: Annals of translational medicine
Published: January 12, 2022
Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors.
Journal: Translational cancer research
Published: September 22, 2021
Erratum to clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.
Journal: Annals of palliative medicine
Published: December 23, 2019
Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.
Journal: Annals of palliative medicine
Published: September 10, 2019
Downregulation of SPARC Expression Decreases Cell Migration and Invasion Involving Epithelial-Mesenchymal Transition through the p-FAK/p-ERK Pathway in Esophageal Squamous Cell Carcinoma.
Journal: Journal of Cancer
Published: November 12, 2018
Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis.
Journal: Journal of Cancer
Published: July 31, 2018
Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.
Journal: The American journal of pathology
Published: July 27, 2017
Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin's lymphoma: A prospective study of 46 cases.
Journal: Molecular and clinical oncology
Published: February 27, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026